Navigation Links
Kevin Garrity Named President of HollisterStier Allergy

SPOKANE, Wash. April 26, 2011 /PRNewswire/ -- HollisterStier Allergy announced that they have recently added Kevin Garrity as the president of the business, illustrating the continued investment in the organization by their corporate parent, Jubilant Life Sciences, Ltd (Jubilant).  


Garrity holds over 25 years of healthcare experience, 15 of which involved selling in vitro allergy diagnostic products and services.  Garrity recently held the title of General Manager and Chief Operating Officer for an in vitro diagnostics manufacturer and clinical laboratory service provider dedicated to immune hypersensitivities.  Garrity holds a Bachelor of Science in medical technology and a Master of Business Administration from Texas State University.  

HollisterStier Allergy has recently seen an influx of investment from Jubilant, evidenced by the completion of recent laboratory and production area expansions, the undertaking of research and development projects, and the addition of Garrity to HollisterStier Allergy leadership.

About HollisterStier Allergy

HollisterStier Allergy is a leading manufacturer of high-quality allergy products for the global market.  The organization provides a complete line of products for the testing and treatment of allergies.  HollisterStier Allergy's product portfolio includes many exclusive products, such as the Acetone Precipitated (AP)™ line of extracts and a complete line of skin testing devices including QUINTIP® and ComforTen®.  HollisterStier Allergy is owned by Jubilant Life Sciences, Ltd., and is located in Spokane, Washington.

For more info:

About Jubilant

Jubilant Life Sciences Limited (formerly Jubilant Organosys Ltd) is an integrated Pharma and Life Sciences Company. It is the largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solution (DDDS) provider out of India. The Company provides Life Sciences products and services across the value chain. With 10 world-class manufacturing facilities and a team of ~5700 people across the globe, the Company is committed to deliver value to its customers spread across 60 countries. The Company is well recognized as a 'Partner of Choice' by leading life sciences companies worldwide.

For more info:

Alison Marlin

SOURCE HollisterStier Allergy
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Verenium Appoints Kevin Bracken Vice President of Manufacturing
2. Kevin Kruse Named Executive Director of the Society of Pharmaceutical and Biotech Trainers
3. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
4. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
5. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
6. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
7. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
8. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
9. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
10. Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN(R)
11. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
Post Your Comments:
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
Breaking Biology Technology:
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
Breaking Biology News(10 mins):